Antipsychotics: history, science, and issues
(Book)
"This text provides a comprehensive analysis of antipsychotic medications, covering historical, social, and scientific viewpoints on this important and controversial class of medications. Covers the class of antipsychotic medications in whole, addressing topics ranging from the medications' history and the science of how they actually work in the body to the social and legal implications of antipsychotics; Provides readers with a holistic understanding of an increasingly important class of medications in an accessible format; Presents an unbiased perspective on a class of medications that has been subject to controversy; Serves both as an authoritative reference book for students and as a useful source of practical information that will appeal to a general adult audience"--Provided by publisher.
Notes
Kerner, J., & McCoy, B. (2017). Antipsychotics: history, science, and issues. Santa Barbara, California, Greenwood, an Imprint of ABC-CLIO, LLC.
Chicago / Turabian - Author Date Citation (style guide)Kerner, Jeffrey and Bridget, McCoy. 2017. Antipsychotics: History, Science, and Issues. Santa Barbara, California, Greenwood, an Imprint of ABC-CLIO, LLC.
Chicago / Turabian - Humanities Citation (style guide)Kerner, Jeffrey and Bridget, McCoy, Antipsychotics: History, Science, and Issues. Santa Barbara, California, Greenwood, an Imprint of ABC-CLIO, LLC, 2017.
MLA Citation (style guide)Kerner, Jeffrey, and Bridget McCoy. Antipsychotics: History, Science, and Issues. Santa Barbara, California, Greenwood, an Imprint of ABC-CLIO, LLC, 2017.
Record Information
Last Sierra Extract Time | Mar 22, 2024 07:48:01 PM |
---|---|
Last File Modification Time | Mar 22, 2024 07:48:29 PM |
Last Grouped Work Modification Time | Apr 05, 2024 09:12:39 PM |
MARC Record
LEADER | 05271cam a2200577 i 4500 | ||
---|---|---|---|
001 | 953985102 | ||
003 | OCoLC | ||
005 | 20190306094713.0 | ||
008 | 160916s2017 cau b 001 0 eng | ||
010 | |a 2016042476 | ||
019 | |a 944210439 | ||
020 | |a 9781440839887|q (hardback ;|q alk. paper) | ||
020 | |a 1440839883|q (hardback ;|q alk. paper) | ||
020 | |z 9781440839894|q (ebook) | ||
035 | |a (OCoLC)953985102|z (OCoLC)944210439 | ||
039 | |a 411846|c TLC | ||
040 | |a DLC|b eng|e rda|c DLC|d BTCTA|d OCLCF|d YDXCP|d BDX|d YDX|d IBI|d OCLCO|d OCLCQ|d SAA|d DCK|d OCLCO|d MNM|d OCLCO|d PZF|d OCLCO|d JDP|d HMS|d OCLCA|d CAA | ||
042 | |a pcc | ||
049 | |a CAAA | ||
050 | 0 | 0 | |a RM333.5|b .K47 2017 |
060 | 4 | |a QV 77.9|b K395a 2017 | |
082 | 0 | 0 | |a 615.7/882|2 23 |
100 | 1 | |a Kerner, Jeffrey,|0 https://id.loc.gov/authorities/names/n2016050753|e author. | |
245 | 1 | 0 | |a Antipsychotics :|b history, science, and issues /|c Jeffrey Kerner and Bridget McCoy. |
264 | 1 | |a Santa Barbara, California :|b Greenwood, an Imprint of ABC-CLIO, LLC,|c [2017] | |
300 | |a xv, 234 pages ;|c 25 cm. | ||
336 | |a text|b txt|2 rdacontent | ||
337 | |a unmediated|b n|2 rdamedia | ||
338 | |a volume|b nc|2 rdacarrier | ||
490 | 1 | |a The story of a drug | |
504 | |a Includes bibliographical references (pages 217-219) and index. | ||
505 | 0 | |a ch. 1: Case studies -- Case 1: Jimmy -- Case 2: Bobby -- Case 3: George -- ch.2: What are antipsychotics? -- Psychotic disorders and the symptoms of psychosis -- Treatment of psychosis: from exorcism to antipsychotics -- Typical antipsychotics: the beginning -- Atypical antipsychotics: as the story continues... -- ch.3. Antipsychotics: a brief history -- Early biological remedies: the original antipsychotics -- "A drug in search of an illness": developing antipsychotic medications -- Chlorpromazine rises -- Side effects emerge -- Competition for chlorpromazine -- How antipsychotics are used today: bridging past and future -- ch.4: How antipsychotics work -- Parts of the brain -- What are neurotransmitters and what do they do? -- Neurotransmitters affected by antipsychotics -- Other potential targets -- ch.5: Effects and applications -- Therapeutic effects of antipsychotics -- How well do antipsychotics work? -- Indications for medical use -- Antipsychotic use in special groups -- ch.6: Risks, misuse, and overdose -- Side effects -- Misuse of antipsychotics -- Antipsychotic overdose and toxicity -- ch.7: Production, distribution, and regulation -- Pharmaceutical industry -- Antipsychotics in nursing homes -- Prior authorization -- The unique case of clozapine -- AIMS and metabolic monitoring -- ch.8: The social dimensions of antipsychotics -- Deinstitutionalization -- Antipsychotics and the doctor-patient relationship -- Legal and ethical implications of antipsychotics -- Antipsychotics and political dissent -- Antipsychotics and the elderly -- Antipsychotics and children -- When to treat? The implications of the initiation of antipsychotic treatment -- The business of antipsychotics -- Mental illness and violence -- ch. 9: The future of antipsychotics -- Where are antipsychotics failing? -- Pathophysiology of chronic psychotic disorders -- New medications on the horizon -- Better routes of administration -- Use in nonpsychotic disorders. | |
520 | |a "This text provides a comprehensive analysis of antipsychotic medications, covering historical, social, and scientific viewpoints on this important and controversial class of medications. Covers the class of antipsychotic medications in whole, addressing topics ranging from the medications' history and the science of how they actually work in the body to the social and legal implications of antipsychotics; Provides readers with a holistic understanding of an increasingly important class of medications in an accessible format; Presents an unbiased perspective on a class of medications that has been subject to controversy; Serves both as an authoritative reference book for students and as a useful source of practical information that will appeal to a general adult audience"--Provided by publisher. | ||
650 | 0 | |a Antipsychotic drugs.|0 https://id.loc.gov/authorities/subjects/sh89002390 | |
650 | 0 | |a Antipsychotic drugs|0 https://id.loc.gov/authorities/subjects/sh89002390|x History.|0 https://id.loc.gov/authorities/subjects/sh99005024 | |
650 | 0 | |a Psychoses|x Chemotherapy.|0 https://id.loc.gov/authorities/subjects/sh89002396 | |
650 | 1 | 2 | |a Antipsychotic Agents.|0 https://id.nlm.nih.gov/mesh/D014150 |
650 | 1 | 2 | |a Psychotic Disorders|x therapy.|0 https://id.nlm.nih.gov/mesh/D011618Q000628 |
655 | 7 | |a History.|2 lcgft | |
700 | 1 | |a McCoy, Bridget,|0 https://id.loc.gov/authorities/names/n2016050755|e author. | |
830 | 0 | |a Story of a drug.|0 https://id.loc.gov/authorities/names/no2016117404 | |
907 | |a .b64134428 | ||
948 | |a MARCIVE Comprehensive, in 2023.02 | ||
948 | |a MARCIVE Over, 05/2021 | ||
989 | |1 .i137565616|b 190801982421|d aigci|g -|m |h 0|x 0|t 0|i 0|j 333|k 210501|o -|a RM333.5|r .K47 2017 | ||
994 | |a C0|b CAA | ||
995 | |a Loaded with m2btab.ltiac in 2023.02 | ||
995 | |a Loaded with m2btab.ltiac in 2021.05 | ||
995 | |a Loaded with m2btab.migrate in 2021.04 | ||
995 | |a Loaded with m2btab.auth in 2021.05 | ||
998 | |e -|f eng|a ai |